Option Care Health, Inc.
OPCH
Rang in aandelen
#3631
Option Care Health, Inc. delivers infusion services to patients in their homes... Option Care Health, Inc. delivers infusion services to patients in their homes and other non-hospital settings throughout the United States. The company offers a broad spectrum of specialized infusion treatments, including therapies for various infections, management of heart failure, and comprehensive nutritional support (both intravenous and tube feeding) for individuals with acute or chronic conditions such as stroke, cancer, and digestive illnesses. They also provide immunoglobulin infusions for immune system deficiencies and treatments targeting chronic inflammatory disorders like Crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, and ulcerative colitis. Furthermore, Option Care Health assists in managing the progression of neurological conditions such as amyotrophic lateral sclerosis (ALS) and Duchenne muscular dystrophy. They also administer infusion therapies for bleeding disorders and provide crucial support for women experiencing high-risk pregnancies. Other specialized infusion services encompass pain relief, chemotherapy, and respiratory care. Complementing these medical offerings, the company provides professional nursing services. Option Care Health, Inc. maintains its primary corporate office in Bannockburn, Illinois.
Aandeelprijs
$31.31
Marktkapitalisatie
$4.69B
Verandering (1 dag)
0.30%
Verandering (1 jaar)
10.31%
Land
US
Handel Option Care Health, Inc. (OPCH)
Categorie
Healthcare
P/B-ratio voor Option Care Health, Inc. (OPCH)
P/B-ratio op October 2026 TTM: 3.82
Volgens de meest recente financiële rapporten en aandelenkoers van Option Care Health, Inc. is de huidige P/B-ratio (TTM) 3.82. Eind 2023 had het bedrijf een P/B-ratio van 4.24.
P/B-ratiohistoriek voor Option Care Health, Inc. van 2000 tot 2026
P/B-ratio aan het einde van elk jaar
| Jaar | P/B-ratio | Wijzigen |
|---|---|---|
| 2026 (TTM) | 3.82 | 35.10% |
| 2024 | 2.83 | -33.17% |
| 2023 | 4.24 | 7.88% |
| 2022 | 3.93 | -9.62% |
| 2021 | 4.35 | 56.10% |
| 2020 | 2.79 | 8.37% |
| 2019 | 2.57 | -181.07% |
| 2018 | -3.17 | -28.59% |
| 2017 | -4.44 | 43.80% |
| 2016 | -3.09 | 107.76% |
| 2015 | -1.49 | -167.34% |
| 2014 | 2.21 | 63.86% |
| 2013 | 1.35 | -34.73% |
| 2012 | 2.06 | 49.33% |
| 2011 | 1.38 | 5.00% |
| 2010 | 1.32 | -37.07% |
| 2009 | 2.09 | 134.35% |
| 2008 | 0.89 | -49.01% |
| 2007 | 1.75 | 119.52% |
| 2006 | 0.80 | -39.32% |
| 2005 | 1.31 | 7.48% |
| 2004 | 1.22 | -15.86% |
| 2003 | 1.45 | 4.39% |
| 2002 | 1.39 | -77.75% |
| 2001 | 6.26 | 1,294.92% |
| 2000 | 0.45 | 0.00% |
P/B-ratio voor vergelijkbare bedrijven of concurrenten
| Bedrijf | P/B-ratio | Verschil in P/B-ratio | Land |
|---|---|---|---|
| -15.9433 | -517.01% |
US
|
|
| - | - |
DE
|
|
| 4.8701 | 27.38% |
US
|
|
| 9.3882 | 145.56% |
SA
|
|
| 4.6058 | 20.47% |
BR
|
